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Abstract
Background: The envelope (Env) protein of jaagsiekte sheep retrovirus (JSRV) can transform cells
in culture and is likely to be the main factor responsible for lung cancer induction by JSRV in animals.
A recent report indicates that the epithelial-cell transforming activity of JSRV Env depends on
activation of the cell-surface receptor tyrosine kinase Mst1r (called RON for the human and Stk
for the rodent orthologs). In the immortalized line of human epithelial cells used (BEAS-2B cells),
the virus receptor Hyal2 was found to bind to and suppress the activity of RON. When Env was
expressed it bound to Hyal2 causing its degradation, release of RON activity from Hyal2
suppression, and activation of pathways resulting in cell transformation.
Methods: Due to difficulty with reproducibility of the transformation assay in BEAS-2B cells, we
have used more tractable rodent fibroblast models to further study Hyal2 modulation of RON/Stk
transforming activity and potential effects of Hyal2 on RON/Stk activation by its natural ligand,
macrophage stimulating protein (MSP).
Results: We did not detect transformation of NIH 3T3 cells by plasmids expressing RON or Stk,
but did detect transformation of 208F rat fibroblasts by these plasmids at a very low rate. We were
able to isolate 208F cell clones that expressed RON or Stk and that showed changes in morphology
indicative of transformation. The parental 208F cells did not respond to MSP but 208F cells
expressing RON or Stk showed obvious increases in scattering/transformation in response to MSP.
Human Hyal2 had no effect on the basal or MSP-induced phenotypes of RON-expressing 208F cells,
and human, mouse or rat Hyal2 had no effect on the basal or MSP-induced phenotypes of Stk-
expressing 208F cells.
Conclusions: We have shown that RON or Stk expression in 208F rat fibroblasts results in a
transformed phenotype that is enhanced by addition of the natural ligand for these proteins, MSP.
Hyal2 does not directly modulate the basal or MSP-induced RON/Stk activity, although it is possible
that adaptor proteins might mediate such signaling in other cell types.
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Background
JSRV is an acutely oncogenic retrovirus that can induce
lung tumors in newborn sheep in as little as 10 days [1].
Unlike most acutely oncogenic retroviruses, JSRV does not
carry a host cell-derived oncogene. Instead, expression of
the native viral Env protein is sufficient to transform cul-
tured cells and is likely to be the active oncogene in ani-
mals [2-5]. The only other examples of such retroviruses
are enzootic nasal tumor virus, a close relative of JSRV that
encodes a similar transforming Env protein [6,7]; avian
hemangioma virus [8], which expresses an Env protein
that can induce cell proliferation in cultured cells [9]; and
spleen focus-forming virus, a replication-defective virus
that expresses a recombinant nonfunctional Env protein
that has been shown to induce proliferation in cultured
cells and in animals by activating the erythropoietin
receptor and a short form of the transmembrane receptor
tyrosine kinase Stk [10,11].
At least two mechanisms of transformation by JSRV Env
have been identified in cultured cells. JSRV Env can trans-
form immortalized mouse, rat, and chicken fibroblasts [2-
4], and the cytoplasmic tail of Env is absolutely required
for transformation [4,12-14]. Interaction of the extracellu-
lar domain of Env with the virus receptor Hyal2 appears
to play no role in transformation of the rodent fibroblasts
since JSRV Env does not bind to mouse Hyal2 [15], and
deletion of the Hyal2-binding domain of Env did not
abrogate transformation of rat fibroblasts [16]. Although
there is some controversy regarding the mechanism of
transformation, most studies indicate a role for the phos-
phatidylinositol 3-kinase (PI3K)/Akt pathway in transfor-
mation of the rodent fibroblasts [7,12,13,17]. In contrast,
this pathway appears to play a smaller role in the transfor-
mation of chicken fibroblasts, but other more important
pathways have yet to be identified [4,14].
A second pathway for JSRV Env transformation involves
activation of the transmembrane receptor tyrosine kinase
Mst1r (herein called RON for the human and Stk for the
rodent forms [18,19]). RON/Stk activation is associated
with cell scattering, cell transformation, and oncogenesis
in animals [20]. RON/Stk activity is induced by binding of
its only known ligand, macrophage stimulating protein
(MSP) [21,22]. Recent evidence indicates that the JSRV
receptor Hyal2 is also involved in regulating RON activity
in an immortal human epithelial cell line (BEAS-2B) that
naturally expresses Hyal2 and RON [5]. In its normal
inactive state, RON is bound to Hyal2, and when Hyal2
binding is prevented by JSRV Env, RON becomes consti-
tutively active in the absence of MSP stimulation. Intro-
duction of a dominant negative form of RON into these
cells blocked transformation, indicating that main trans-
formation pathway is through RON and that JSRV might
cause cancer through a novel mechanism involving RON
activation [5]. Thus it appears that JSRV Env can transform
cells by at least two distinct mechanisms. Furthermore,
the dependence of epithelial cell transformation on acti-
vation of the RON pathway, in contrast to fibroblasts,
which do not express RON and are transformed through a
different pathway, indicated that the RON pathway might
be more important in oncogenesis in animals because epi-
thelial cells are the natural target for JSRV-induced cancer
in sheep.
We have had difficulty in further exploring transforma-
tion through the RON pathway in BEAS-2B cells due to
difficulty with reproducibility of the transformation assay.
Others have found that Stk can transform immortalized
rodent fibroblasts [23,24], and we hypothesized that if
Hyal2 does downregulate RON/Stk activity, we might be
able to suppress transformation by RON/Stk by overex-
pressing Hyal2. In addition, we wanted to explore
whether Hyal2 might modulate MSP induction of RON/
Stk activity. Here, we have been able to generate 208F rat
fibroblasts that express either RON or Stk and find that
these cells exhibit a transformed phenotype in compari-
son to the parental cells. Treatment of the cells with MSP
induced a dose-dependent increase in scattering/transfor-
mation. Using a variety of approaches we have been una-
ble to detect an effect of Hyal2 on the constitutive or MSP-
induced phenotypes of 208F cells expressing RON or Stk.
These results argue against a direct role for Hyal2 in the
regulation of RON/Stk activity.
Methods
Cell culture
Cell lines used here include 208F Fischer rat embryo
fibroblasts [25], a morphologically flat subclone of NIH
3T3 Swiss mouse embryo fibroblasts suitable for transfor-
mation studies (gift from Maxine Linial, Fred Hutchinson
Cancer Research Center, Seattle; originally from Doug
Lowy, National Cancer Institute, Bethesda), PJ4/LAPSN
packaging cells [26] that produce the LAPSN retroviral
vector [27] with a JSRV pseudotype, and PT67 10A1-MLV-
pseudotype retrovirus packaging cells [28]. Unless other-
wise stated, cells were grown in Dulbecco's modified Eagle
medium (DMEM) with high glucose (4.5 g/L) and 10%
fetal bovine serum at 37°C in a 10% CO2-air atmosphere
at 100% relative humidity.
Expression plasmids
Mouse Stk was expressed by using a plasmid (gift from
Sandra Ruscetti, National Cancer Institute, Frederick, Mar-
yland) that contains the mouse Stk cDNA cloned into the
NotI site of the pAlter-Max expression plasmid (Promega,
Madison, Wisconsin). Human RON was expressed by
using a plasmid (gift from Michael Lerman, National Can-
cer Institute, Frederick, Maryland) that contains the
human RON cDNA inserted into the pCI-neo expressionBMC Cancer 2004, 4:64 http://www.biomedcentral.com/1471-2407/4/64
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plasmid (Promega). The expression cassette in both of
these plasmids is identical and consists of a human
cytomegalovirus immediate early promoter followed by
splicing signals, the cDNA, and the simian virus 40 late
polyadenylation signal. Mouse Stk was also expressed
using the previously described pcDNA3-based expression
vector [23] (gift from Susan Waltz, University of Cincin-
nati, Ohio), which contains the human cytomegalovirus
early promoter, no splice signals, and the bovine growth
hormone polyadenylation signal. Human RON was also
expressed using the previously described retroviral vector
expression plasmid pMSCVpuroRON [5], in which the
RON cDNA is expressed from the Moloney murine leuke-
mia virus promoter and the puromycin resistance gene is
expressed using a phosphoglycerate kinase promoter. In
this vector both spliced and unspliced mRNAs are made
that encode RON.
Retroviral vectors
The LAPSN retroviral vector encodes human placental
alkaline phosphatase (AP) and neomycin phosphotrans-
ferase (Neo). LAPSN virus was made using PT67 (10A1-
MLV pseudotype) or PJ4 (JSRV pseudotype) packaging
cells. Retroviral vectors encoding human Hyal1, human
Hyal2, mouse Hyal2 cloned from NIH 3T3 cells, and rat
Hyal2 cloned from 208F rat cells (GenBank accession
numbers U03056, U09577, AF535140, and AF535141,
respectively) were made by insertion of the cDNAs into
the LXSN vector [29] and by generation of stable PT67 ret-
rovirus packaging cell lines that produce the vectors as
described [3,15,29]. The human Hyal1 and human Hyal2
vectors present in the packaging cell clones that were used
are known to be functional based on phenotypic assays of
the proteins made in cells transduced with the vectors [3].
Two independent packaging cell clones that produce the
rat Hyal2 vector and two independent clones that produce
the mouse Hyal2 vector were used, and the correct
sequence of the cDNAs in the integrated vectors in these
packaging cells was confirmed by PCR amplification of
the sequences followed by complete sequencing of the
cDNAs.
Cell transformation assay
NIH 3T3 and 208F cells were transfected using calcium
phosphate as previously described [15] and were moni-
tored for appearance of transformed foci of cells for up to
a month after transfection.
Cellular response to MSP
Recombinant human MSP activated by treatment with
kallikrein (R&D Systems, Minneapolis, MN) was dis-
solved at a concentration of 10 µg/ml in phosphate buff-
ered saline with calcium and magnesium containing 0.2%
bovine serum albumin and was stored at -70°C. Cells
were seeded at 10,000 per well (d = 16 mm) of 24-well
plates. Two days after seeding, the cells were treated with
0.06 to 20 µl of MSP stock in 0.5 ml of fresh medium
(MSP concentration of 1.2 to 400 ng/ml) and cellular
morphology was evaluated the day after MSP addition.
Treatment of cells with 20 µl buffer containing 0.2%
bovine serum albumin in 0.5 ml of fresh medium had no
effect on cell morphology.
Results
RON and Stk exhibit low transforming activity in rodent 
fibroblasts
We tested plasmids encoding RON or Stk (pCIneoRON
and pAlter-Max-Stk, respectively) for transforming activity
in NIH 3T3 mouse and 208F rat fibroblasts. The cDNAs in
both plasmids were driven by a strong human cytomega-
lovirus immediate early promoter and each contained an
intron to promote high-level expression. In these assays,
strong oncogenes induce transformed foci of cells in less
than a week while less active oncogenes take longer to
induce foci. In both cases the numbers of foci generally
increase with time after transfection.
Neither the RON nor the Stk expression plasmid induced
transformed foci in NIH 3T3 cells (<0.2 foci per µg plas-
mid DNA at one month after transfection), while a plas-
mid expressing JSRV Env (pSX2.Jenv) induced 33 well-
developed foci per µg plasmid DNA under the same con-
ditions. This result is consistent with previous reports
showing a lack of transformation by human RON [30-32],
but is inconsistent with reports indicating efficient trans-
formation of NIH 3T3 cells by mouse Stk (called "Ron" in
these reports) [23,24]. We obtained the Stk expression
plasmid used by the latter group (full-length mouse Ron
cDNA in pcDNA3), and again could not detect transfor-
mation of NIH 3T3 cells by this plasmid (<0.2 foci per µg
plasmid DNA at one month after transfection). There was
some background focal growth in all plates of transfected
NIH 3T3 cells one month after transfection, but this
growth was identical in plates transfected with RON/Stk
or control expression plasmids. In contrast, foci induced
by JSRV Env were distinct and readily detected at 2 weeks
after transfection.
Next we tested for transformation of 208F rat fibroblasts
by the RON and Stk plasmids. The Stk plasmid (pAlter-
Max-Stk) induced 3 clear foci in a total of 7 dishes (0.2
foci per µg plasmid DNA), and the RON plasmid (pCIne-
oRON) induced 1 clear focus in a total of 5 dishes (0.1
foci per µg plasmid DNA) (foci counted 1 month after
transfection, 2 µg plasmid DNA per dish, 2–3 separate
experiments for each plasmid). The Stk expression plas-
mid pcDNA3Stk used in the earlier studies [23,24] did not
induce transformed foci in the 208F cells (<0.1 foci per µg
plasmid DNA). For comparison, the JSRV Env expression
plasmid induced 300 to over 500 foci per dish whenBMC Cancer 2004, 4:64 http://www.biomedcentral.com/1471-2407/4/64
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counted 2 weeks after transfection under the same condi-
tions. Together these results document a very low trans-
forming activity for the RON and Stk genes.
Generation of cells expressing RON and Stk that respond 
to MSP
Foci of transformed 208F cells were isolated from plates of
cells transfected with the RON or Stk expression plasmids
and were tested for their response to MSP. Cells trans-
formed by the RON plasmid were not responsive to MSP
and were discarded. Cells transformed by the Stk plasmid
were responsive to MSP, and two clones (208F/Stk c12
and c13) were used for further study. Both of these clones
made Stk protein of the appropriate molecular weight as
judged by western analysis using RON/Stk-specific anti-
bodies (data not shown).
The response of 208F/Stk c13 cells to overnight treatment
with MSP is shown in Fig. 1. Without MSP the cells were
elongated and formed chains of connected cells (Fig. 1,
top right panel), in contrast to the parental 208F cells
which grow as flat uniformly-expanding colonies (Fig. 1,
top left panel). Treatment of the 208F/Stk c13 cells with
MSP resulted in dramatic scattering (Fig. 1, bottom right
panel) while treatment of the parental 208F cells with
MSP had no effect on cell morphology (Fig. 1, bottom left
panel). The MSP response was fully reversible; incubation
of cells overnight in regular growth medium reversed the
scattering induced by MSP and chains of cells reformed
(not shown). 208F/Stk c12 cells exhibited an even more
transformed appearance than did 208F/Stk c13 cells, and
many of these cells would grow in suspension, often as
doublets of what appeared to be recently divided cells.
These floating cells could be repeatedly regrown in new
plates, showing that the cells were alive and were not sim-
ply undergoing apoptosis. Passage of the floating cells
provided a simple method for maintaining the trans-
formed phenotype of these cells, which tended to decrease
with time of culture.
Since we were unsuccessful in generating 208F cells
expressing functional RON by isolation of transformed
cells following transfection, we isolated RON-expressing
cells by transfection with a RON expression vector that
also expressed a selectable marker (pMSCVpuroRON),
grew the cells in puromycin to select for cells expressing
the marker, and isolated multiple cell clones that showed
a weakly-transformed phenotype. These clonal lines were
screened for scattering response to MSP, and two inde-
pendent clones that had the most transformed appear-
ance and that responded to MSP (208F/RON c9 and c10)
were identified and used in further analyses. Both clones
produced RON protein of the appropriate size band by
western analysis using a RON/Stk-specific antibodies, and
both exhibited clear surface expression of RON by FACS
analysis using a RON-specific antibody while control
208F cells showed no expression (data not shown). The
208F/RON clones had a less obvious transformed pheno-
type than the 208F/Stk clones but still showed convincing
scattering in response to MSP (see below).
Hyal2 expression does not affect the phenotype of cells 
expressing RON or Stk
We tested whether overexpression of Hyal2 would reverse
the altered phenotype of 208F cells expressing RON or
Stk. Since the original work in BEAS-2B human cells
showed inhibition of RON activity by human Hyal2 [5],
we tested human Hyal2 in the 208F/RON cells. In 208F/
Stk cells we tested mouse and rat Hyal2, as well as human
Hyal2, in case the rodent proteins might show more effec-
tive interaction with mouse Stk in the rat cells. To quanti-
tate the effect of Hyal2 expression on cell phenotype, cells
were seeded at low density and colonies that grew out
were scored for morphology, either round and flat, round
and refractile, chain-like, or scattered. Fig. 2 shows exam-
ples of the phenotypes exhibited by 208F/Stk c13 cells.
The top panel shows examples of chain-like (left) and flat
(right) colonies, the middle panel shows an example of a
chain-like colony, and the bottom panel shows an exam-
ple of a scattered colony. In initial experiments we found
that transduction of the cells with control vectors encod-
ing either AP or Hyal1 had no effect on cell morphology
(data not shown), and we used these vectors as negative
controls for the effects of vector transduction in subse-
quent experiments.
We exposed 208F cells that expressed RON to retroviral
vectors encoding human Hyal2, AP, or human Hyal1,
grew these cells in G418 to select for cells expressing the
vector, and quantitated the morphologies of the cells that
grew out. The experiment was repeated by replating the
G418-resistant cells at low density and repeating the mor-
phologic quantitation. The results were similar for both
cell lines in both experiments so the results for the two
experiments with each of the two cell lines were averaged
(Fig. 3). There was no significant change in morphology
of the cells expressing human Hyal2 in comparison to
those expressing human Hyal1 or AP, arguing against the
hypothesis that Hyal2 can inhibit the activity of RON.
Indeed, cells expressing human Hyal2 exhibited fewer flat
colonies and more chain-like colonies than the other cell
types, the opposite of what the hypothesis predicts,
although these differences were not statistically significant
(Fig. 3). To confirm that Hyal2 was expressed in these
cells, we measured transduction of the cells by a JSRV-
pseudotype retroviral vector, which cannot infect rat cells
unless they express a functional Hyal2 receptor [15]. We
confirmed that only the 208F/RON cells transduced with
the human Hyal2 vector, and not those transduced with
the human Hyal1 vector, were susceptible to JSRV-pseu-BMC Cancer 2004, 4:64 http://www.biomedcentral.com/1471-2407/4/64
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dotype LAPSN vector transduction, showing that func-
tional human Hyal2 was indeed expressed in these cells
(data not shown).
Next we exposed the 208F/Stk c12 and c13 clonal cell
lines to retroviral vectors encoding mouse, rat or human
Hyal2, or human Hyal1, grew these cells in G418 to select
for cells expressing the vector, and quantitated the mor-
phologies of colonies that grew after plating the cells at
low density (Fig. 4). There were no consistent changes in
morphology in response to any of the Hyal2 proteins by
comparison to cells expressing Hyal1 or no additional
protein. To test for expression of the Hyal2 proteins in
these cells, we exposed the cells to JSRV-pseudotype
LAPSN vector and measured the transduction rate (Table
1). As expected based on previous results [15], 208F/Stk
cells expressing no additional protein or expressing
human Hyal1 were not transduced, cells expressing
human Hyal2 were transduced efficiently, cells expressing
rat Hyal2 were transduced at about 1/3 the rate of cells
expressing human Hyal2, and cells expressing mouse
Hyal2 were not transduced. Acquisition of JSRV vector
susceptibility by the normally resistant rat 208F cells fol-
lowing transfer of the human and rat Hyal2 vectors indi-
cates that the Hyal2 genes are expressed in functional
forms. We cannot conclude from this assay that mouse
Hyal2 is expressed in cells transduced with the mouse
Hyal2 vector, but the integrated vectors in both packaging
Scattering of 208F/Stk cells in response to MSP Figure 1
Scattering of 208F/Stk cells in response to MSP. 208F (left panels) and 208F/Stk c13 cells (right panels) were seeded at 2 × 104 
cells per well in 24-well plates. Two days later the cells were treated overnight with 400 ng/ml MSP in growth medium (DMEM 
plus 10% FBS) (bottom panels) or with medium alone (top panels) and were photographed.
208F/Stk
208F/Stk+MSP
208F
208F+MSPBMC Cancer 2004, 4:64 http://www.biomedcentral.com/1471-2407/4/64
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lines that were used to make the mouse Hyal2 vectors
were sequenced and found to have the correct mouse
Hyal2 sequence, so it is likely that normal mouse Hyal2
protein was expressed in the transduced 208F/Stk cells.
Together these results indicate that the Hyal2 proteins
were expressed in the transduced 208F/Stk cells and argue
against the hypothesis that Hyal2 can inhibit the activity
of Stk.
Hyal2 overexpression in RON- or Stk-expressing 208F cells 
does not affect their response to MSP
To quantitate cellular responses to MSP, cells seeded two
days earlier were exposed to MSP at concentrations from
1.2 to 400 ng/ml (in half-log intervals) and the next day
the cell morphology was examined. We measured the
minimum MSP concentration at which an alteration in
morphology was observed and the MSP concentration
above which no further morphologic changes were
observed. The right panels of Fig. 1 show an example of
such extremes of morphology.
The original studies showing an interaction between
RON/Stk and Hyal2 studied the human proteins [5], so
we first examined the effects of human Hyal2 on the MSP
response of 208F/RON cells. Identical responses to MSP
were observed for 208F/RON c9 and 208F/RON c10 cells
that expressed human Hyal2, human Hyal1, or AP. The
responses were first noticeable at 4 ng/ml MSP and were
maximal at 120 ng/ml MSP. These results indicate that
Morphology of 208F/Stk colonies Figure 2
Morphology of 208F/Stk colonies. Cells were seeded 5 days 
before photographs were taken. See text for descriptions.
Colony morphology of 208F/RON cells is unaffected by  Hyal2 expression Figure 3
Colony morphology of 208F/RON cells is unaffected by 
Hyal2 expression. 208F/RON c9 and c10 cells were trans-
duced with retrovirus vectors expressing the indicated pro-
teins, the cells were seeded at low density, and colony 
morphologies were evaluated 1 week after seeding. Results 
are means of four experiments (two for each clone) and 
standard errors are shown.
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Hyal2 does not modulate the activation of RON in
response to MSP.
We next explored the possible effects of Hyal2 on the MSP
response of 208F/Stk cells. We tested human, mouse, and
rat Hyal2 proteins to address the possibility that only the
rodent Hyal2 proteins would interact with Stk. Identical
responses to MSP were observed for 208F/Stk c12 cells
that expressed mouse, rat, or human Hyal2, human
Hyal1, or no protein. In two independent experiments,
the first effects were observed at 1.2 ng/ml MSP and the
maximum effect was observed at 12 ng/ml. Identical
responses were also observed for 208F/Stk c13 cells that
expressed mouse, rat, or human Hyal2, human Hyal1, or
no protein. In this case, the responses were first noticeable
at 4 ng/ml MSP and were maximal at 40 ng/ml MSP.
Untreated 208F/Stk c12 cells are more refractile and
express more Stk than the 208F/Stk c13 cells (data not
shown), and the higher level and basal activity of Stk in
these cells likely explains their higher sensitivity to MSP.
Discussion
The ability of JSRV Env to transform cells in culture, the
identification of Hyal2 as the cell-surface receptor for the
Env protein of JSRV, and the localization of Hyal2 to the
chromosome 3p21.3 lung cancer tumor suppressor locus
suggested the hypothesis that JSRV might cause cancer by
inhibiting a tumor suppressor activity of Hyal2 [3].
Support for this hypothesis was provided by transforma-
tion studies in the human bronchial epithelial cell line
BEAS-2B, which indicated that Hyal2 could suppress the
transforming activity of the RON tyrosine kinase, and that
JSRV Env expression caused Hyal2 degradation and RON
activation [5]. The fact that a dominant-negative kinase-
dead version of RON could block transformation by JSRV
Env in BEAS-2B cells indicated that the RON pathway was
required for transformation.
Unfortunately and despite numerous attempts we have
been unable to reliably measure transformation in BEAS-
2B cells using the originally described expression plas-
mids and transfection techniques [5]. Occasionally we
Colony morphology of 208F/Stk cells is unaffected by Hyal2 expression Figure 4
Colony morphology of 208F/Stk cells is unaffected by Hyal2 expression. 208F/Stk c12 and c13 cells were transduced with ret-
rovirus vectors expressing the indicated proteins or were not transduced (None), the cells were seeded at low density, and 
colony morphologies were evaluated 1 week after seeding. In the right panel, the numbers of flat (bottom black bar) and 
refractile (top black bar) colonies were counted separately. In the left panel these categories were combined. The experiment 
was repeated with similar results.
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observe transformed foci following transfection of the
JSRV Env expression plasmid, but often cells transfected
with a control non-transforming plasmid exhibit similar
foci. We are able to obtain reproducible and obvious
transformation of BEAS-2B cells by transducing the cells
with a retroviral vector encoding JSRV Env (LJeSN vector,
ref. [6]), so presumably the lack of reproducibility is due
to poor Env expression following transfection. To avoid
these difficulties we pursued further studies of the RON
pathway in rodent fibroblast cell lines that have tradition-
ally been used in transformation assays.
Based on earlier findings that Stk could transform NIH
3T3 mouse fibroblasts [23,24], we attempted to isolate
cells expressing RON or Stk by isolating transformed foci
of cells following transfection of NIH 3T3 cells. However,
we were unable to detect transformation of NIH 3T3 cells
by RON or Stk expression plasmids, consistent with
results from other groups for RON [30-32] and for Stk
(Kazuo Nishigaki and Sandra Ruscetti, personal commu-
nication). Furthermore, we were unable to repeat the
studies showing transformation of NIH 3T3 cells by Stk
when we used the same Stk expression plasmid used in
the earlier reports [23,24]. These reports showed a very
high background transformation rate in the NIH 3T3 cells
(50 foci per µg control DNA, ref. [24]; see photographs of
cell culture dishes in Fig. 2 of ref. [23]) casting doubt on
the reliability of the transformation assay. Unless a very
flat subclone of NIH 3T3 cells is used in these assays, as we
used here, a high and variable background transformation
rate can be observed. Even here we observed a level of
background morphologic changes in the NIH 3T3 cells
such that low levels of transformation would be difficult
to detect.
In contrast, the 208F cells showed no background trans-
formation and allowed us to detect a low frequency of
transformation by RON and Stk. This low rate of transfor-
mation could be due to a requirement for a very high level
of RON/Stk expression that occurs only in a small number
of cells, or a requirement for mutations that activate the
RON/Stk proteins and occur at low frequency. We isolated
several foci of Stk-transformed 208F cells and found that
these cells expressed Stk protein of the expected size by
western blotting and that the cells responded to MSP,
indicating that the Stk protein was not constitutively acti-
vated by mutations or deletions, and suggesting that the
protein is simply overexpressed in these cells. In contrast,
cells from the one focus of cells transformed by transfec-
tion of the RON gene were unresponsive to MSP and thus
might have been the result of activating mutations or dele-
tions in RON. To generate 208F cells expressing RON we
transfected RON with a selectable marker and isolated
cells showing a weakly transformed phenotype.
We presume that the low level phenotypic alteration
observed in 208F/RON and 208F/Stk cells in the absence
of MSP addition is due either to low-level constitutive
activity of RON/Stk or to RON/Stk activation by low levels
of MSP made by the cells or present in the culture
medium. Given that the parental 208F cells show no
response to MSP, we conclude that the cell scattering phe-
notype observed after addition of MSP is a direct measure
of RON/Stk activation. The transformed phenotype of
these cells in the absence of added MSP and the scattering
phenotype observed after treatment of the cells with MSP
seem to represent variations of the same transformation
phenotype. Indeed, 208F cells transformed by other onco-
genes, including JSRV Env, exhibit a scattered phenotype
similar to MSP treated 208F cells expressing RON or Stk.
Furthermore, 208F cells expressing RON or Stk can exhibit
a scattered phenotype in the absence of added MSP, espe-
cially if the cells are selected for a highly transformed phe-
notype by passaging substrate-independent cells that float
Table 1: Assay for functional expression of Hyal2 proteins in 208F/Stk cells transduced with Hyal2-expressing retroviral vectors
Source of vector used to transduce cells LAPSN(PJ4) vector titer (AP+ FFU/ml) on cells:
208F/Stk c12 208F/Stk c13
No vector <10 <10
PT67/LhHyal1SN c16 <10 <10
PT67/LhHyal2SN c16 2,000 2,000
PT67/LrHyal2SN c2 800 600
PT67/LrHyal2SN c12 600 600
PT67/LmHyal2SN c7 <10 <10
PT67/LmHyal2SN c8 <10 <10
208F/Stk c12 and 208F/Stk c13 cells were exposed to vectors from the indicated vector-producing packaging cell lines and were exposed to G418 
to select for expression of the vector. The cells were then exposed to JSRV-pseudotype LAPSN vector from PJ4/LAPSN cells and the apparent 
titers were determined.BMC Cancer 2004, 4:64 http://www.biomedcentral.com/1471-2407/4/64
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in the culture medium. Given this interpretation, the
response of the RON/Stk-expressing cells to MSP can be
considered a form of ligand-dependent transformation,
similar to what has been observed previously for cells
expressing the receptors for human colony-stimulating
factor 1 [33], insulin-like growth factor I [34], granulo-
cyte/macrophage colony-stimulating factor [35], and a
hybrid EGF receptor/Xmrk tyrosine kinase [36].
Alternatively, it may be that the basal and MSP-induced
phenotypes of the RON/Stk-expressing cells are mediated
by separate signaling pathways, as has been found for the
related receptor tyrosine kinase MET [37]. These investiga-
tors found that a MET oncogene could induce trans-
formed foci and an invasion phenotype in cultured rat
fibroblasts, which when injected into nude mice would
form tumors and would metastasize to the lungs. Two
point mutations in the MET oncogene completely abro-
gated the invasion and metastasis phenotypes but did not
affect the transformation and tumorigenesis phenotypes
of the MET oncogene, indicating that separable signaling
pathways were involved.
We did not find any effect of human Hyal2 on the basal
phenotype or the response to MSP of the 208F/RON cells,
nor did we find an effect of human, rat, or mouse Hyal2
on the basal phenotype or the MSP response of 208F/Stk
cells. These results argue against direct regulation of RON
activity by Hyal2 as was indicated by prior experiments
using BEAS-2B cells [5]. It is possible that additional fac-
tors present in BEAS-2B but not in 208F cells are required
for regulation of RON activity by Hyal2.
Recently we have found that Env proteins from JSRV and
from the related retrovirus enzootic nasal tumor virus
(ENTV) can transform Madin-Darby canine kidney
(MDCK) epithelial cells, but by a mechanism different
from that observed in BEAS-2B cells and similar to that
observed in rodent fibroblast cell lines [38]. In particular,
the cytoplasmic tail of Env is required for transformation,
the PI3K/Akt pathway is activated and inhibition of PI3K
activity reverses the transformed phenotype, expression of
RON (which is not normally expressed in MDCK cells)
does not affect transformation, and canine Hyal2
expressed by these cells appears uninvolved. These results
show that the JSRV Env protein can transform epithelial
cells besides BEAS-2B cells, and argue against a model for
Env transformation involving different pathways that are
uniquely active in epithelial cells as compared to fibrob-
lasts. Future work will focus on the transformation path-
ways that are active in lung tumors induced in animals by
JSRV Env. While it is possible that the RON pathway plays
a role in oncogenesis, most of the evidence points to a
main role for the cytoplasmic domain of Env and activa-
tion of the PI3K/Akt pathway.
Conclusions
We have shown that expression of the mouse or human
orthologs of the receptor tyrosine kinase Mst1r (called
RON in humans and Stk in rodents) can induce pheno-
typic changes indicative of transformation in a rat fibrob-
last cell line. These changes are enhanced by treatment of
the cells with MSP, the natural ligand for RON/Stk, which
induces a pronounced scattering/transformation
response. Transformation of the BEAS-2B immortalized
human epithelial cell line by JSRV appears to require RON
activation, as a result of JSRV Env binding to and degrada-
tion of the virus receptor Hyal2, which appeared to nega-
tively regulate RON activity. However, we find no
evidence for direct regulation of the basal or MSP-induced
RON/Stk activity by Hyal2 in rat fibroblasts.
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